ARTICLE
21 November 2024

Holland & Knight Health Dose: November 19, 2024

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • House Passes Slate of Health-Related Legislation
  • E&C Marks Up Telehealth Extension and Other Health Bills
  • Senate HELP Committee Ranking Member Requests information from Two Largest Contract Pharmacies
  • Democrats Show Support for Extending ACA APTC Subsidies
  • MACPAC Holds September 2024 Public Meeting
  • Long-Anticipated MDRP Rule Released by CMS
  • CMS Releases Updated Medicaid Guidance
  • DOJ Petitions Supreme Court on Preventative Care

Read the full Health Dose ยป

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More